Company registration number 10982713 (England and Wales)
SOLUVOS MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH REGISTRAR
SOLUVOS MEDICAL LTD
BALANCE SHEET
AS AT
31 DECEMBER 2023
31 December 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
44,442
-
0
Current assets
322,134
182,339
Prepayments and accrued income
10,401
275
Creditors: amounts falling due within one year
(144,853)
(78,721)
Net current assets
187,682
103,893
Total assets less current liabilities
232,124
103,893
Creditors: amounts falling due after more than one year
(2,140)
(2,050)
Net assets
229,984
101,843
Capital and reserves
229,984
101,843
Notes to the financial statements
1
Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £57,872 (2022: £0).

 

 

Amounts disclosed in the balance sheet

Included in the balance sheet are unpaid pension contributions of £257 (2022: £0).

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2023
2022
Number
Number
Employees
1
-
0

Soluvos Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is International House, 36-38 Cornhill, London, EC3V 3NG.

For the year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

SOLUVOS MEDICAL LTD
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2023
31 December 2023
- 2 -

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

The directors of the company have elected not to include a copy of the financial profit and loss account within the financial statements that are filed.

 

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

(e) the company has relied on the specified exemption as a micro company contained in section 352 Companies Act 2014; the company has done so on the grounds that it is entitled to the benefit of that exemption as a small company and we confirm that the abridged financial statements have been properly prepared in accordance with section 353 Companies Act 2014.true

The financial statements were approved by the board of directors and authorised for issue on 8 April 2024 and are signed on its behalf by:
Mr. J. Doomernik
Director
Company registration number 10982713 (England and Wales)
2023-12-312023-01-01falseCCH SoftwareCCH Accounts Production 2023.300Mr. J. DoomernikMs. R. HenrichsMs. C. Voskoufalse109827132023-01-012023-12-31109827132023-12-31109827132022-12-3110982713core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3110982713core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3110982713core:Non-currentFinancialInstruments2023-12-3110982713core:Non-currentFinancialInstruments2022-12-31109827132022-01-012022-12-3110982713bus:Director12023-01-012023-12-3110982713bus:PrivateLimitedCompanyLtd2023-01-012023-12-3110982713bus:SmallCompaniesRegimeForAccounts2023-01-012023-12-3110982713bus:Micro-entities2023-01-012023-12-3110982713bus:AuditExemptWithAccountantsReport2023-01-012023-12-3110982713bus:Director22023-01-012023-12-3110982713bus:Director32023-01-012023-12-3110982713bus:FullAccounts2023-01-012023-12-31xbrli:purexbrli:sharesiso4217:GBP